Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) today announced the beneficiaries of five $50,000 funding honors to support application patient navigation agendas directed toward underprivileged populations at most danger of evolving SLE and LN. Each patient-focused group will receive assets to provision their planned one-year trial agendas Each non-profit patient-focused group will […]